T. K. Larsen, I. Melle, and B. Auestad, Early detection of psychosis: positive effects on 5-year outcome, Psychol Med, vol.41, issue.7, pp.1461-1469, 2011.

P. Fusar-poli, S. Borgwardt, and A. Bechdolf, The psychosis high-risk state: a comprehensive state-of-the-art review, JAMA Psychiatry, vol.70, issue.1, pp.107-120, 2013.

P. Fusar-poli, I. Bonoldi, and A. R. Yung, Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk, Arch Gen Psychiatry, vol.69, issue.3, pp.220-229, 2012.

S. Zammit, D. Kounali, and M. Cannon, Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study, Am J Psychiatry, vol.170, issue.7, pp.742-750, 2013.

C. Healy, R. Brannigan, and N. Dooley, Childhood and adolescent psychotic experiences and risk of mental disorder: a systematic review and meta-analysis, Psychol Med, vol.49, issue.10, pp.1589-1599, 2019.

C. Healy, D. Campbell, H. Coughlan, M. Clarke, I. Kelleher et al., Childhood psychotic experiences are associated with poorer global functioning throughout adolescence and into early adulthood, Acta Psychiatr Scand, vol.138, issue.1, pp.26-34, 2018.

P. Mcgorry, M. Keshavan, and S. Goldstone, Biomarkers and clinical staging in psychiatry, World Psychiatry, vol.13, issue.3, pp.211-223, 2014.

, UK Public General Acts. Human Tissue Act, 2004.

J. Van-os, B. P. Rutten, and I. Myin-germeys,

, Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations, Schizophr Bull, vol.40, issue.4, pp.729-736, 2014.

, Psychiatry, vol.39, pp.964-971, 2005.

J. A. English, L. M. Lopez, and A. O'gorman, Blood-based protein changes in childhood are associated with increased risk for later psychotic disorder: evidence from a nested case-control study of the ALSPAC longitudinal birth cohort, Schizophr Bull, vol.44, issue.2, pp.297-306, 2018.

I. H. Aas, Global Assessment of Functioning (GAF): properties and frontier of current knowledge, Ann Gen Psychiatry, vol.9, p.20, 2010.

H. H. Goldman, A. E. Skodol, and T. R. Lave, Revising axis V for DSM-IV: a review of measures of social functioning, Am J Psychiatry, vol.149, issue.9, pp.1148-1156, 1992.

N. C. Andreasen, The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations, Br J Psychiatry Suppl, issue.7, pp.49-58, 1989.

J. E. Overall and D. R. Gorham, The Brief Psychiatric Rating Scale, Psychological Reports, vol.10, issue.3, pp.1121-1128, 1962.

L. Laskaris, A. Zalesky, and C. S. Weickert, Investigation of peripheral complement factors across stages of psychosis, Schizophr Res, vol.204, pp.30-37, 2019.

D. Baumeister, A. Russell, C. M. Pariante, and V. Mondelli, Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors, Soc Psychiatry Psychiatr Epidemiol, vol.49, issue.6, pp.841-849, 2014.

A. Sekar, A. R. Bialas, and H. De-rivera,

, Schizophrenia Working Group of the Psychiatric Genomics Consortium. Schizophrenia risk from complex variation of complement component 4, Nature, vol.530, issue.7589, pp.177-183, 2016.

S. Hoirisch-clapauch, O. B. Amaral, M. A. Mezzasalma, R. Panizzutti, and A. E. Nardi, Dysfunction in the coagulation system and schizophrenia, Transl Psychiatry, vol.6, 2016.

A. A. Rehman, H. Ahsan, and F. H. Khan, ?-2-Macroglobulin: a physiological guardian, J Cell Physiol, vol.228, issue.8, pp.1665-1675, 2013.

R. Upthegrove, N. Manzanares-teson, and N. M. Barnes, Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis, Schizophr Res, vol.155, issue.1-3, pp.3345-3353, 1992.

. Baker, . Sk, Z. L. Chen, E. H. Norris, A. S. Revenko et al., Blood-derived plasminogen drives brain inflammation and plaque deposition in a mouse model of Alzheimer's disease, Proc Natl Acad Sci U S A, vol.115, issue.41, pp.9687-9696, 2018.

U. Amara, M. A. Flierl, and D. Rittirsch, Molecular intercommunication between the complement and coagulation systems, J Immunol, vol.185, issue.9, pp.5628-5636, 2010.

J. K. Ryu, M. A. Petersen, and S. G. Murray, Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation, Nat Commun, vol.6, p.8164, 2015.

T. A. Pollak, S. Drndarski, J. M. Stone, A. S. David, P. Mcguire et al., The blood-brain barrier in psychosis, Lancet Psychiatry, vol.5, issue.1, pp.30293-30299, 2018.

J. K. Ryu, V. A. Rafalski, and A. Meyer-franke, Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future, Transl Psychiatry, vol.19, issue.11, p.160, 2018.

S. Westwood, E. Leoni, and A. Hye, Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly, J Alzheimers Dis, vol.52, issue.2, pp.561-572, 2016.

S. Ripke, B. M. Neale, and A. Corvin,

, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Nature, vol.511, issue.7510, pp.421-427, 2014.

T. C. Fung, C. A. Olson, and E. Y. Hsiao, Interactions between the microbiota, immune and nervous systems in health and disease, Nat Neurosci, vol.20, issue.2, pp.145-155, 2017.

G. M. Khandaker, J. Zimbron, G. Lewis, and P. B. Jones, Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies, Psychol Med, vol.43, issue.2, pp.239-257, 2013.

L. Rasmussen, T. E. Moffitt, and L. Arseneault, Association of adverse experiences and exposure to violence in childhood and adolescence with inflammatory burden in young people, JAMA Pediatr, vol.174, issue.1, pp.1-11, 2019.

J. Van-os, G. Kenis, and B. P. Rutten, The environment and schizophrenia, Nature, vol.468, issue.7321, pp.203-212, 2010.